These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 399520

  • 21. HLA gene dosage effect on renal allograft survival.
    Kim KH, Jung HY, Choi JY, Cho JH, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD.
    Transplant Proc; 2015 Apr; 47(3):635-9. PubMed ID: 25891701
    [Abstract] [Full Text] [Related]

  • 22. Desensitization--which renal allograft recipients are suitable?
    Thick M.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):738-9. PubMed ID: 3274858
    [No Abstract] [Full Text] [Related]

  • 23. [HLA-amino acid residue matching in organ transplantation].
    Tan J, Tang X, Zhou Y.
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):31-3. PubMed ID: 11831982
    [Abstract] [Full Text] [Related]

  • 24. Effect of HLA matching on renal transplant survival.
    Zhou YC, Cecka JM.
    Clin Transpl; 1993 Jan; ():499-510. PubMed ID: 7918184
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Molecular HLA matching.
    Terasaki PI, Takemoto S, Park MS, Cecka JM, Mickey MR.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):365-7. PubMed ID: 1990554
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients.
    Shoskes DA, Hodge EE, Goormastic M, Goldfarb DA, Novick AC.
    Transplant Proc; 1995 Feb; 27(1):1068-9. PubMed ID: 7878808
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ, Bayne AM, Welsh KI, Morris PJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract] [Full Text] [Related]

  • 33. The significance of HLA-A, -B matching for the survival of cadaveric kidney transplants performed in Stockholm in 1970-78.
    Berg B, Gunnarsson R, Lundgren G, Magnusson G, Möller E, Groth CG.
    Scand J Urol Nephrol Suppl; 1980 Feb; 54():41-3. PubMed ID: 7013041
    [Abstract] [Full Text] [Related]

  • 34. How can HLA matching improve kidney graft survival?
    van Rood JJ, Persijn GG, Lansbergen Q, Cohen B, van Leeuwen A, Bradley BA.
    Proc Eur Dial Transplant Assoc; 1979 Feb; 16():297-304. PubMed ID: 398498
    [No Abstract] [Full Text] [Related]

  • 35. The influence of HLA-DR matching on renal transplant outcome.
    Ting A, Morris PJ.
    Transplant Proc; 1979 Jun; 11(2):1295. PubMed ID: 382516
    [No Abstract] [Full Text] [Related]

  • 36. Renal transplant rejection. Transient immunodominance of HLA mismatches.
    Gilks WR, Gore SM, Bradley BA.
    Transplantation; 1990 Jul; 50(1):141-6. PubMed ID: 2368134
    [Abstract] [Full Text] [Related]

  • 37. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 Jul; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 38. Effect of blood transfusions and HLA matching on renal transplantation in the Netherlands.
    Persijn GG, van Hooff JP, Kalff MW, Lansbergen Q, van Rood JJ.
    Transplant Proc; 1977 Mar; 9(1):503-5. PubMed ID: 325789
    [No Abstract] [Full Text] [Related]

  • 39. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
    Singal DP, Joseph S, Szewczuk MR.
    Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
    [No Abstract] [Full Text] [Related]

  • 40. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N, Ho E, King DW, Yu YP, Yu-Kai S, Reed E, Cohen D, Brensilver JM, McCabe R, Rose E.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.